Camille C. Gunderson

Dr. Camille C. Gunderson


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2013 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CGCamille C. Gunderson
Camille C. Gunderson
ENElizabeth K. Nugent
Elizabeth K. Nugent
SEStacie H. Elfrink
Stacie H. Elfrink
MGMichael A. Gold
Michael A. Gold
KMKathleen N. Moore
Kathleen N. Moore

1 December 2016 in Gynecologic Oncology
Verified
Journal Article
Open access
AFAmanda N. Fader
Amanda N. Fader
JJJames Java
James Java
MTMeaghan Tenney
Meaghan Tenney
SRStephanie Ricci
Stephanie Ricci
CGCamille C. Gunderson
Camille C. Gunderson
JWJOAN LESLIE WALKER
JOAN LESLIE WALKER
We sought to analyze the clinicopathologic features, recurrence patterns and survival outcomes of women with high-grade uterine cancer (UC) enrolled on The Gynecologic Oncology Group (GOG) LAP2 trial. This is a post-hoc analysis of LAP-2 patients with grade 3 endometrioid adenocarcinoma (ENDO), uterine serous (USC), clear cell (CC) and carcinosarcoma (CS). Demographics, clinicopathologic features, and recurrence patterns, were compared by histology and surgical approach. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Of the 2600 patients enrolled in LAP-2, 753 patients had high-grade UC: 350 had ENDO, 289 had USC, 42 had CC and 72 had CS. Compared with the ENDO cohort, those with other high-grade subtypes were older (p<0.001) and were more likely to have positive peritoneal cytology (p<0.001), positive lymph nodes (p=0.05) and higher disease stage on final pathology (p<0.001). With a median follow-up time of 60months, compared to patients with ENDO, those with USC, CCC and CS subtypes had higher recurrence rates (p<0.001), extra-pelvic recurrences (p<0.001) and poorer PFS (p<0.001) and OS (p<0.001). Those diagnosed with USC and CS experienced the worst survival outcomes (p=0.003). Patterns of recurrence and survival were not different in those staged with LSC vs LAP. On multivariable analysis, age, stage, pelvic washings and Type II histology were independently and adversely associated with survival. Women with apparent early-stage, USC and CS histologies have poorer outcomes than women with grade 3 endometrioid adenocarcinoma. Patterns of recurrence and survival were not impacted by surgical approach.

31 October 2020 in Gynecologic Oncology
Verified
Journal Article
Closed access
SESuganthapriya Elayapillai
Suganthapriya Elayapillai
SRSatishkumar Ramraj
Satishkumar Ramraj
DBDoris Mangiaracina Benbrook
Doris Mangiaracina Benbrook
MBMagdalena Bieniasz
Magdalena Bieniasz
LWLin Wang
Lin Wang
CGCamille C. Gunderson
Camille C. Gunderson

1 July 2014 in Gynecologic Oncology
Verified
Journal Article
Closed access
CGCamille C. Gunderson
Camille C. Gunderson
ETEric D. Thomas
Eric D. Thomas
KSKatrina N. Slaughter
Katrina N. Slaughter
RFRegina Farrell
Regina Farrell
KDKai Ding
Kai Ding
KMKathleen N. Moore
Kathleen N. Moore

1 July 2013 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
CGCamille C. Gunderson
Camille C. Gunderson
ENElizabeth K. Nugent
Elizabeth K. Nugent
DMD. Scott McMeekin
D. Scott McMeekin
KMKathleen N. Moore
Kathleen N. Moore